Jump to content

Intriptyline

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by 79.71.68.198 (talk) at 15:04, 8 December 2022 (Synthesis). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Intriptyline
Skeletal formula of intriptyline
Space-filling model of the intriptyline molecule
Clinical data
ATC code
  • none
Identifiers
  • N,N-dimethyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)but-2-yn-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H19N
Molar mass285.390 g·mol−1
3D model (JSmol)
  • C(#C\C=C3/c1ccccc1\C=C/c2c3cccc2)CN(C)C
  • InChI=1S/C21H19N/c1-22(2)16-8-7-13-21-19-11-5-3-9-17(19)14-15-18-10-4-6-12-20(18)21/h3-6,9-15H,16H2,1-2H3
  • Key:OKCODFSHDQKCQN-UHFFFAOYSA-N

Intriptyline is a tricyclic antidepressant (TCA) that was never marketed.[1]

Synthesis

Patents:[2][3]

The Grignard reaction between dibenzocycloheptadienone (Dibenzosuberenone) [2222-33-5] (1) propargyl bromide [106-96-7] (2) with leads to carbinol, CID:139102035 (3). A Mannich reaction with formaldehyde and dimethylamine leads to (4). which, upon dehydration with SOCl2 and pyridine, was transformed into intriptyline (5).

See also

References

  1. ^ Ganellin CR, Triggle DJ, MacDonald F (1997). Dictionary of pharmacological agents - Google Books. ISBN 978-0-412-46630-4.
  2. ^ Cavalla, J. F.; White, A. C, GB 1406481  (1975 to Wyeth John & Brother Ltd).
  3. ^ FR2005201 idem E Ber, J Cognacq, F Dvolaitzky, U.S. patent 3,723,420 (1973 to Auguil Soc Civ).